Wolverine Asset Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Wolverine Asset Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-189,151	Closed	-$274K	–	1885
2024 Q1	$274K	Buy	189,151 +101,956	+117%	+$62.5K	﹤0.01%	918
2023 Q4	$8.71K	Buy	87,195 +54,640	+168%	+$4.08K	﹤0.01%	1402
2023 Q3	$4.88K	Buy	+32,555	New	+$4.62K	﹤0.01%	1562
2022 Q1	–	Sell	-50,076	Closed	-$25K	–	2500
2021 Q4	$25K	Sell	50,076 -1,000	-2%	-$553	﹤0.01%	1667
2021 Q3	$29K	Sell	51,076 -6,000	-11%	-$4.39K	﹤0.01%	1548
2021 Q2	$57K	Buy	+57,076	New	+$43.3K	﹤0.01%	1630

Wolverine Asset Management's AEON.WS Position: Q2 2024 in Review

Wolverine Asset Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 189,151 shares — an estimated $274K sold.

Wolverine Asset Management first reported a position in AEON.WS in Q2 2021 and held it in 6 quarters. The position peaked at $274K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Wolverine Asset Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Wolverine Asset Management sold 189,151 AEON Biopharma Inc shares in Q2 2024, an estimated $274K.
Wolverine Asset Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 6 quarters.
Wolverine Asset Management's AEON Biopharma Inc position peaked at $274K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.